Overall rank by patents
#22,081
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
Zhejiang Huakang Pharmaceutical Co., Ltd.
USPTO PatentsView assignee record — 13 granted patents across 23 technology areas, active 2023–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C13K (SACCHARIDES OBTAINED FROM NATURAL SOURCES OR BY HYDROLYSIS OF NATURALLY OCCURRING DISACCHARIDES, OLIGOSACCHARIDES OR POLYSACCHARIDES).
13
Total patents granted
23
CPC technology areas
7.8
Avg claims per patent
—
5-year filing velocity
Portfolio overview
Zhejiang Huakang Pharmaceutical Co., Ltd. has been granted 13 US utility patents between 2023 and 2025, placing Zhejiang Huakang Pharmaceutical Co., Ltd. at rank #22,081 across all assignees tracked by PlainPatent. This portfolio spans 23 distinct Cooperative Patent Classification (CPC) subclasses, averaging 7.8 claims per patent with primary concentration in C13K (SACCHARIDES OBTAINED FROM NATURAL SOURCES OR BY HYDROLYSIS OF NATURALLY OCCURRING DISACCHARIDES, OLIGOSACCHARIDES OR POLYSACCHARIDES). As a Foreign Corporation, Zhejiang Huakang Pharmaceutical Co., Ltd. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 50.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2023 through 2025, with 13 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Zhejiang Huakang Pharmaceutical Co., Ltd.'s 7.8 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while a multi-domain presence across 23 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Zhejiang Huakang Pharmaceutical Co., Ltd. against peers pursuing similar technology classes.
How does Zhejiang compare?
Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀
- Samsung
SAMSUNG ELECTRONICS CO., LTD.
106,890 patents
- International Bus…
International Business Machines Corporation
72,926 patents
- Canon 34,378
Canon Kabushiki Kaisha
34,378 patents
- LG 32,607
LG ELECTRONICS INC.
32,607 patents
- Taiwan Semiconduc… 31,041
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LTD.
31,041 patents
- Apple 30,560
Apple Inc.
30,560 patents
- Qualcomm Incorpor… 30,354
QUALCOMM Incorporated
30,354 patents
- Intel 27,498
Intel Corporation
27,498 patents
- Zhejiang Huakang… ◀ 13
Zhejiang Huakang Pharmaceutical Co., Ltd.
13 patents
What this shows Zhejiang holds 13 patents — placing it at rank #22,081 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.
USPTO utility patent grants by year · 2023–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2023 | 2 | 15.4% |
| 2024 | 5 | 38.5% |
| 2025 | 6 | 46.2% |
Which technologies does Zhejiang Huakang Pharmaceutical Co., Ltd. patent most?
Top 15 of 23 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Multi-domain
Claim Depth Simple
Frequently Asked Questions
How many patents does Zhejiang Huakang Pharmaceutical Co., Ltd. hold?
Zhejiang Huakang Pharmaceutical Co., Ltd. holds 13 US granted patents filed between 2023 and 2025, spanning 23 technology areas.
What is Zhejiang Huakang Pharmaceutical Co., Ltd.'s Innovation Score?
Zhejiang Huakang Pharmaceutical Co., Ltd. has an Innovation Score of 50.7 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Zhejiang Huakang Pharmaceutical Co., Ltd. focus on?
Zhejiang Huakang Pharmaceutical Co., Ltd.'s top technology area is C13K (SACCHARIDES OBTAINED FROM NATURAL SOURCES OR BY HYDROLYSIS OF NATURALLY OCCURRING DISACCHARIDES, OLIGOSACCHARIDES OR POLYSACCHARIDES) with 5 patents. The company has filed patents in 23 CPC subclasses total.
Is Zhejiang Huakang Pharmaceutical Co., Ltd.'s patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for Zhejiang Huakang Pharmaceutical Co., Ltd..
What does claim depth mean for Zhejiang Huakang Pharmaceutical Co., Ltd.'s patents?
Zhejiang Huakang Pharmaceutical Co., Ltd.'s patents average 7.8 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the Zhejiang Huakang Pharmaceutical Co., Ltd. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
Learn More
Explore the patent dataset
C13K technology
Zhejiang Huakang Pharmaceutical Co., Ltd.'s primary CPC class — all holders and yearly trends
Top 50 patent holders
See where Zhejiang Huakang Pharmaceutical Co., Ltd. ranks among the largest US patent assignees
All technology classes
Browse every CPC technology area by patent activity
How the score works
The four dimensions behind the Innovation Score
Related
Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
All federal data sources used on this page
- USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
- USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
- USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
- USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
- SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
- WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope
